Learn to track real recovery in major depressive disorder by monitoring mood, energy, cognition, and quality of life for ...
Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company leading a new era in the treatment of central nervous ...
In the early phases of depression and psychosis, patients often show altered inflammatory markers in the blood and structural ...
"A single dose of DMT with psychotherapeutic support produced a rapid, significant reduction in depressive symptoms, ...
Depression is a complex and deeply personal experience. While almost everyone has periods of sadness, low mood or grief, ...
Intra-Cellular Therapies’ surging antipsychotic Caplyta has scored again with remarkable trial results, fueling its bid for a third and potentially most lucrative indication—major depressive disorder ...
A team of leading clinical research scientists from the Departments of Psychiatry and Dermatology at the Icahn School of ...
The approval of medicines called second-generation antipsychotics has allowed major depressive disorder (MDD) and other conditions linked to it to be treated. A person with MDD is usually prescribed ...